According to recent research, diallyl trisulfide has shown anticancer effects in breast cancer stem cells by decreasing ALDH activity and down-regulating forkhead box Q1 (FOXQ1) protein activity. This evidence concerns the gene FOXQ1 and breast carcinoma.